iTeos Therapeutics Inc. (ITOS)
undefined
undefined%
At close: undefined
7.68
0.13%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 12.60M 267.63M 344.77M - - -
Cost of Revenue 898.00K 813.00K 615.00K 535.00K 611.00K 505.00K
Gross Profit 11.70M 266.82M 344.16M -535.00K -611.00K -505.00K
Operating Income -151.10M 126.32M 244.90M -45.24M -28.05M -21.50M
Interest Income 31.77M 11.36M 78.00K - - -
Pretax Income -109.03M 148.74M 256.46M -38.09M -22.34M -18.05M
Net Income -112.64M 96.65M 214.52M -38.03M -22.45M -18.06M
Selling & General & Admin 50.40M 43.95M 40.51M 15.34M 8.84M 4.31M
Research & Development 113.30M 97.36M 59.37M 29.90M 19.21M 17.19M
Other Expenses - -3.26M -10.18M -5.93M -4.78M -163.00K
Operating Expenses 163.70M 138.04M 89.69M 39.31M 23.27M 17.82M
Interest Expense - - - - - 66.00K
Selling & Marketing Expenses - - - - - -
Cost & Expenses 163.70M 138.04M 89.69M 39.31M 23.27M 17.82M
Income Tax 3.61M 52.08M 41.94M -57.00K 119.00K 11.00K
Shares Outstanding (Basic) 35.76M 35.55M 35.18M 35.04M 35.02M 7.51M
Shares Outstanding (Diluted) 35.76M 37.77M 37.77M 35.04M 35.02M 7.51M
EPS (Basic) -3.15 2.72 6.10 -1.09 -0.64 -2.4
EPS (Diluted) -3.15 2.56 5.68 -1.09 -0.64 -2.4
EBITDA -151.10M 148.38M 257.08M -37.84M -21.72M -17.48M
Depreciation & Amortization 898.00K 813.00K 615.00K 535.00K 611.00K 505.00K